Joanne M. Donovan, CMO of Edgewise Therapeutics ($EWTX), sold shares on the open market twice in the last year, totaling about $124,000. Her most recent sale occurred on August 12, 2025. These sales rank her 9,261st among 11,678 insiders by value, well below the average of $8.6 million per seller across 6 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 28662 | $7.08 | 38,259.0000 | 102,930,744 | 298.66% | 0.03% |
| April 1, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 28662 | $32.31 | 9,597.0000 | 102,930,744 | 74.92% | 0.03% |
| April 1, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 28662 | $0.00 | 125,000.0000 | 102,930,744 | 18.65% | 0.03% |
| March 31, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 21338 | $0.00 | 153,662.0000 | 102,930,744 | 12.19% | 0.02% |
| March 31, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 21338 | $32.12 | 9,597.0000 | 102,930,744 | 68.98% | 0.02% |
| March 31, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 21338 | $7.08 | 30,935.0000 | 102,930,744 | 222.34% | 0.02% |
| March 27, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 9623 | $30.98 | 16,332.0000 | 102,930,744 | 37.08% | 0.01% |
| March 27, 2026 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 6735 | $30.98 | 9,597.0000 | 102,930,744 | 41.24% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 5781 | $0.00 | 28,223.0000 | 104,940,493 | 25.76% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 2862 | $13.39 | 25,361.0000 | 104,940,493 | 10.14% | 0.00% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | A | Restricted Stock Units | 28125 | $0.00 | 28,125.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 104,940,493 | 9999.99% | 0.16% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Restricted Stock Units | 10417 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 10417 | $0.00 | 26,775.0000 | 95,130,053 | 63.68% | 0.01% |
| May 2, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 5187 | $16.45 | 21,588.0000 | 95,130,053 | 19.37% | 0.01% |
| Jan. 28, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 175,000.0000 | 92,414,626 | 12.50% | 0.03% |
| Jan. 28, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 25000 | $27.63 | 16,358.0000 | 92,414,626 | 60.45% | 0.03% |
| Jan. 28, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 25000 | $7.08 | 41,358.0000 | 92,414,626 | 152.83% | 0.03% |
| Sept. 20, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 7162 | $28.29 | 14,538.0000 | 93,515,356 | 33.00% | 0.01% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| May 2, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | S | Common Stock | 3682 | $18.91 | 19,897.0000 | 87,567,307 | 15.62% | 0.00% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Common Stock | 10417 | $0.00 | 23,579.0000 | 87,567,307 | 79.14% | 0.01% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Donovan Joanne M. | CMO | M | Restricted Stock Units | 10417 | $0.00 | 10,417.0000 | 87,567,307 | 50.00% | 0.01% |